Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, will participate in the Sidoti Ninth Annual Micro-Cap Conference in New York City on May 9, 2014.
Help employers find you! Check out all the jobs and post your resume.
